The Role of Radiotherapy in Patients with Refractory Hodgkin Lymphoma after Brentuximab Vedotin and -/or Immune Checkpoint InhibitorsRui Zhao, Yin Yang, Ganggang Shi et al.|International Journal of Radiation Oncology*Biology*Physics|2023Cited by 0